Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
J X Wang Department of
Obstetrics and Gynaecology, University of Adelaide, Queen Elizabeth
Hospital, Woodville, SA 5011, Australia
Correspondence to: J X Wang jwang{at}medicine.adelaide.edu.au
Being underweight or overweight has an adverse effect on
reproduction.
1 2
Overweight women have a higher incidence
of menstrual dysfunction and anovulation, possibly because of altered secretion of pulsatile gonadotropin releasing hormone, sex hormone binding globulin, ovarian and adrenal androgen, and luteinising hormone
and also because of altered insulin resistance. The prevalence of
obesity in infertile women is high, but there is no conclusive evidence
that extremes of weight are associated with a low rate of pregnancy in
women receiving assisted reproduction treatment. This study examined
whether body mass index (weight (kg)/(height (m)2)) is associated with reduced fecundity (the
probability of achieving at least one pregnancy during treatment) in
women receiving assisted reproduction treatment.
The participants were 3586 women who received assisted
reproduction treatment between 1987 and 1998 in a tertiary medical unit
in Adelaide, South Australia. Treatments included in vitro fertilisation (n=1972), intracytoplasmic sperm injection (n=1040), and
gamete intrafallopian transfer (n=574). Patients underwent 8822 embryo
transfer cycles. The overall implantation rate was 12.0%, and the
clinical pregnancy rate was 24.1% in the study population. Causes of
infertility included tubal blockage (34%), semen defects (35%),
unexplained infertility (16%), and endometriosis (9%). Age of
participants, treatment modalities, location of the treatment, number
of embryos transferred, number of cycles of embryo transfer, and number
of oocytes recovered were analysed to eliminate possible confounding
effects. Polycystic ovarian syndrome was diagnosed, using normal
criteria, in 25% (881/3586) of the women.3
Participants were stratified into five groups according to body
mass index: "underweight" (<20), "moderate" (20.0-24.9),
"overweight" (25.0-29.9), "obese" (30.0-34.9), and "very
obese" ( The number of treatment cycles and embryos transferred per cycle did
not differ among the groups, but age varied significantly but
unsystematically (table). There was a significant linear
reduction in fecundity from the moderate group to the very obese group
(P<0.001). The fecundity of the moderate group was almost 60% higher
than that of the very obese group, and the fecundity of the underweight group was also significantly lower than that of the moderate group (P<0.05), indicating an "inverted U" relation between body mass index and fecundity.
![]()
Participants, methods, and results
Top
Participants, methods, and...
Commentary
References
35). Fecundity was defined as the probability of achieving
at least one pregnancy throughout the treatment. Pregnancy was
determined by ultrasonography of the embryonic sac (or sacs) in the
womb at 4-6 weeks after embryo transfer. The clinical protocols have
been described elsewhere.4 We compared the groups by using
analysis of variance and a
2 test. We assessed the
effect of body mass index, controlling for the confounding factors, by
logistic regression.
Logistic regression analysis confirmed the independent effect of body
mass on fecundity. When the significant effects of maternal age, number
of embryos transferred, number of cycles received, treatment type, and
cause of infertility were controlled for, the pregnancy rate among very
obese women was half that of the moderate group. Polycystic ovarian
syndrome had an independent effect on fecundity.
| |
Commentary |
|---|
|
|
|---|
A body mass index that was either high or low was associated
with reduced probability of achieving pregnancy in women receiving assisted reproduction treatment. Mechanisms through which body mass
affects reproduction that have been cited include menstrual disturbance
and anovulation,5 but these problems can be overcome through assisted reproduction treatment. There is no evidence that body
mass affects the quality of the embryo and therefore the pregnancy
rate. We propose that other mechanisms, such as altered receptivity of
the uterus after transfer of embryos or oocytes, possibly because of
disturbed endometrial function, may cause reduced fecundity.
| |
Acknowledgments |
|---|
We thank the staff of the Reproductive Medicine Unit in Adelaide for their contribution.
Contributors: JXW and RJN conceived and designed the study. JXW analysed and interpreted the data and wrote the paper. MD assisted in the analysis and interpretation of data, and MD and RJN revised the paper.
| |
Footnotes |
|---|
Funding: No additional funding.
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. |
Correa H, Jacoby J.
Nutrition and fertility: some iconoclastic results.
Am J Clin Nutr
1978;
31:
1431-1436 |
| 2. |
Frisch RE.
Body weight and reproduction [letter].
Science
1989;
246:
432 |
| 3. | Norman RJ, Masters SC, Hague W, Beng C, Pannall P, Wang JX. Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil Steril 1995; 63: 329-335[Medline]. |
| 4. |
Norman RJ, Warnes GM, Wang X, Kirby CA, Matthews CD.
Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
Hum Reprod
1991;
6:
206-213 |
| 5. | Lake JK, Power C, Cole TJ. Women's reproductive health: the role of body mass index in early and adult life. Int J Obes Relat Metab Disord 1997; 21: 432-438[CrossRef][Medline]. |
(Accepted 2 July 2000)
Read all Rapid Responses